Tuesday, September 05, 2006 |
10:00:00 AM |
Eric Green |
Bldg 549 Auditorium |
|
Techniques for Genome Mapping and Sequencing
|
Details
Series
|
Friday, September 08, 2006 |
11:00:00 AM |
Terry Van Dyke, PhD |
Bldg 549 Auditorium |
|
Deciphering the Complexities of Cancer in Mouse Models
|
Details
|
|
12:00:00 PM |
Rachel Caspi, Ph.D. |
Bldg 426 Conf. Rm |
|
Dependence on Innate Immune Responses for Generation of Effector and Regulatory T Cells in a Model of Retinal Autoimmunity
|
Details
Series
|
Tuesday, September 12, 2006 |
8:30:00 AM |
Steven M. Larson, MD |
Bldg 549 Conf. Rm B |
|
Molecular Imaging and Targeted Radiotherapy in Oncology
|
Details
Series
|
|
10:00:00 AM |
Andy Baxevanis |
Bldg 549 Auditorium |
|
Nucleotide and Protein Sequence Analysis I
|
Details
Series
|
|
12:30:00 PM |
Jonathan Stoye, Ph.D. |
Bldg 549 Auditorium |
|
Functional Studies of Retroviral Restriction Factors
|
Details
|
Thursday, September 14, 2006 |
8:30:00 AM |
Various Speakers |
Bldg 549 Auditorium |
|
Glycosciences in Cancer Workshop 2006: Progress and Potential
|
Details
|
|
11:30:00 AM |
Dr. David Threadgill |
Bldg 549 Auditorium |
|
Genetic Architecture of Colorectal Cancer Suseptibility
|
Details
|
Friday, September 15, 2006 |
8:30:00 AM |
Various Speakers |
Bldg 549 Auditorium |
|
Glycosciences in Cancer Workshop 2006: Progress and Potential
|
Details
|
|
12:00:00 PM |
Dr. James Williamson |
Bldg 549 Auditorium |
|
A Post-Proteomic Approach to Ribosome Assembly
|
Details
Series
|
|
12:00:00 PM |
Jianping Ye, M.D. |
Bldg 426 Conf. Rm |
|
Hypoxia and Inflammation in Metabolic Syndrome
|
Details
Series
|
Tuesday, September 19, 2006 |
5:00:00 AM |
Samuel Strober, MD |
Bldg 549 Conf. Rm B |
|
Harnessing the Power of Graft Anti-tumor Activity after Bone Marrow Transplantation
|
Details
Series
|
|
9:30:00 AM |
Dr. Yuri Nedialkov |
Bldg 539, Rm 126D |
|
Conformational Coupling Between the Active Site and the Translocation Apparatus in RNA Polymerase 11
|
Details
|
|
10:00:00 AM |
Andy Baxevanis |
Bldg 549 Conf. Rm B |
|
Nucleotide and Protein Sequence Analysis II
|
Details
Series
|
|
2:00:00 PM |
Michael Scott |
Bldg 549 Conf. Rm A |
|
New Stategies for Biomarker Discovery
|
Details
Series
|
|
3:00:00 PM |
Dr. Chuxia Deng |
Bldg 549 Auditorium |
|
Breast Cancer Suppressor Gene 1 (BRACA1) and Tumorigenesis
|
Details
|
Wednesday, September 20, 2006 |
9:00:00 AM |
Professor M.A. Waslk |
Bldg 549 Auditorium |
|
Interdependence of Cell Signaling and Epigenetic Gene Silencing in Carcinogenesis
|
Details
Series
|
|
12:00:00 PM |
Sergei Nedospasov |
Bldg 549 Auditorium |
|
Physiological Functions of Tumor Necrosis Factor and the Consequences of TNF Ablation: The Farewell Seminar
|
Details
Series
|
Friday, September 22, 2006 |
12:00:00 PM |
Dr. Domenico Mavilio |
Bldg 426 Conf. Rm |
|
Role of the Innate Immunity in the Pathogenesis of HIV-1 Infection
|
Details
Series
|
Monday, September 25, 2006 |
2:00:00 PM |
Dr. Matthias Bochtler |
Bldg 549 Auditorium |
|
Restriction Enzymes and Their Cleavage Patterns From a Structural Perpective
|
Details
|
Tuesday, September 26, 2006 |
8:30:00 AM |
Javed Khan, MD |
Bldg 549 Conf. Rm B |
|
Translational "omics" in Cancer
|
Details
Series
|
|
10:00:00 AM |
Tyra Wolfsberg |
Bldg 549 Auditorium |
|
Mining Genomic Sequence Data
|
Details
Series
|
Wednesday, September 27, 2006 |
8:30:00 AM |
Various Speakers |
|
|
Molecular Targets Faculty Retreat
|
Details
|
Thursday, September 28, 2006 |
8:00:00 AM |
Various Speakers |
Bldg 10 Masur |
|
Frontiers in Basic Immunology
|
Details
|
|
12:15:00 PM |
Dr. Zbigniew Dauter |
Bldg 536 Conf Rm |
|
How to Make Your Structure Difficult
|
Details
|
Friday, September 29, 2006 |
8:00:00 AM |
Various Speakers |
Bldg 10 Masur |
|
Frontiers in Basic Immunology
|
Details
|
|
11:00:00 AM |
Dr. Jianhua Fu |
Bldg 549 Auditorium |
|
Determining RNA Polymerase 11-Capping Enzyme Complex Structure Using a Novel Approach for Large Complex Crystallography
|
Details
|
|
3:00:00 PM |
Sunghoon Kim, PhD |
Bldg 549 Conf. Rm B |
|
Functional Versatility of Human tRNA Synthetases and Their Associated Factors: Implications for Human Diseases and Therapeutic Applications
|
Details
Series
|